Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Smith

Showing results (411-420 of 530) with videos related to

Pageof 53
Sort By:
Acta Neuropathologica Communications|February 17, 2018
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945Nicolau Beckmann, Elisa Giorgetti, Anna Neuhaus, et al.
BJU International|February 9, 2012
Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive casesG Igor Pinkhasov, Yu-Kuan Lin, Ricardo Palmerola, et al.
Membranes|September 22, 2022
The Effects of Cholesterol Oxidation on Erythrocyte Plasma Membranes: A Monolayer StudyBob-Dan Lechner, Paul Smith, Beth McGill, et al.
The Lancet. Oncology|December 4, 2012
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studyPasi A Jänne, Alice T Shaw, José Rodrigues Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trialPaul A Fields, William Townsend, Andrew Webb, et al.
Science Advances|August 9, 2024
Cyclin F-EXO1 axis controls cell cycle-dependent execution of double-strand break repairHongbin Yang, Shahd Fouad, Paul Smith, et al.
International Journal of Clinical Pharmacy|August 27, 2024
Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinicAngharad Thomas, Paul Forsyth, Ciara Griffiths, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Blood|September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignanciesNelofer Syed, Paul Smith, Alexandra Sullivan, et al.
British Journal of Haematology|July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective studyN George Mikhaeel, David Cunningham, Nicholas Counsell, et al.
Pageof 53

Showing results (411-420 of 530) with videos related to

Sort By:
Pageof 53
Acta Neuropathologica Communications|February 17, 2018
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945Nicolau Beckmann, Elisa Giorgetti, Anna Neuhaus, et al.
BJU International|February 9, 2012
Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive casesG Igor Pinkhasov, Yu-Kuan Lin, Ricardo Palmerola, et al.
Membranes|September 22, 2022
The Effects of Cholesterol Oxidation on Erythrocyte Plasma Membranes: A Monolayer StudyBob-Dan Lechner, Paul Smith, Beth McGill, et al.
The Lancet. Oncology|December 4, 2012
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studyPasi A Jänne, Alice T Shaw, José Rodrigues Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trialPaul A Fields, William Townsend, Andrew Webb, et al.
Science Advances|August 9, 2024
Cyclin F-EXO1 axis controls cell cycle-dependent execution of double-strand break repairHongbin Yang, Shahd Fouad, Paul Smith, et al.
International Journal of Clinical Pharmacy|August 27, 2024
Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinicAngharad Thomas, Paul Forsyth, Ciara Griffiths, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Blood|September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignanciesNelofer Syed, Paul Smith, Alexandra Sullivan, et al.
British Journal of Haematology|July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective studyN George Mikhaeel, David Cunningham, Nicholas Counsell, et al.
Pageof 53